throbber
-.......:....'..;......_.................;......~..........__........
`
`-
`
`-
`
`-
`
`~-~~~'-~~-~~ ~-~-~~
`
`'
`
`.
`
`REVIEW A1€Ta’CLE
`
`ExcEp§en€s and Their use in Enfieaiahée Pmdufis
`
`S&f\§E1‘=EEPNEMA*.. R. J. WASHKUHN, and R. J. ERENDEL
`
`fifaliiizcicragif ffiiesiicsxi, §‘::s:12r5mrg7fm’, Swim’ Lam‘.-s, M;'s_-ramri
`
`
`A8STRA£'Ji".- I-‘ormui.-m'oia ofa n.ewcz'r1.-g p.rm.?ae::.' wirix excipierrrs, rim: !:m*e beer: prcw'm.v5I_3' azfsierf :0 cm app:'o1‘cd
`:'::je‘z:en£v!e ;2ro:;«‘a:cr, mr:_;‘ .:':m3 plaarvsrczrezsrfca,’ mxzrgiazxrierrr cfmz-!0p:'::c.r.‘I;1.? A‘i.'.':-E‘
`rears’ can‘. The" PI3_)rss'c:'mis’ Dari;
`fi°9j3:*re:2ce{P£)R)<1i.=(f ?iar:ribs:.u'; an .£’nj.=z:.'t-;'.'ba‘c? E~‘.r:szg:: 1t'<3r‘::‘:*€3'ie:1‘e(.f',
`e.=..°c£mcr;”rag rd’! i::j'c=m:<r.‘:'<Ji2 an c,:‘c:'pEem.s. ?"I:«:
`:':2_for:::zzifwz ;v;r:; cs;;sm'f(fa:‘crf {ma eight rssirfes. a‘fl!eg(.irizi1:g se.>:c:'_ru'c:1t: as I) Soireazsfis mm’ Cr)-.'so.’s"a=2z!.S', 2)
`SoIe:rBi!Ezz':sg. Wetting, S5:sp¢‘m.’i:eg, En:1iI.§{fl.'i)zg sr Tirickmzfsrg age.r:s.:':, 3} ilfieizzrirsg Agesm, 4} ./~i:2rfa.w:r’cizzm’;»' mm’
`Redracivzg Agems, 5) .~‘miin1:’c:'o:‘::"m’ Pr»;=ssn=ai:’:'e3_. 5) Bag§“ers and pH Aa’jse:rif.u'g Agems,
`I’) Bssikiazg Agcamv,
`P:“a:"ec!-rm!.s. mad ?"0m'c.-iiy A<{r‘z:.::o:'s_. mm’ 8) Sp¢s::3'a§ ziea‘a'.r':a“s>es. W:'.=er+.? ::p_;::’.ic:r:1=.F’c,
`Inf:-Hes hsz freqzrcncy Q,’ me,
`e;‘0:rcem‘rm'ior:, am’ an c.m:::p!c afar mm::m.='cir:.5' _:2roc!:rc.r ::a;:m:':aa“r:g L-'19 e.¥ca):z:'e::f. Exc£;2£e::i.c :s*i:s‘ca‘r<xa'ef1zc?1szfrd in
`the 19915 .-'*‘:’)A ‘;'.uzzcr:'v£ !:zgn":di2uea (.r’m'x;’e, ’ Em: sic rm: :T{Jp€'-car
`in she .r"}’)!«.‘ ar Hmarflraoiq 0:; Izijccmlaie Drugs‘, mu-:3
`:'pzcImz’ed as .5: segmj-me? fist. L
`
`
`introduction
`
`lzajectabie gsroduczs requira. :3 unique forxnufiaiion strzxieggy.
`Ths Eannuiaicsi product has in be steriie. gnymgezx Free and,
`in the :::::a:: mi Sitiiullimifi, {me of pamicuieaic matter. Prat zlzrabiy.
`me fmnulaiion wiii bx‘: iscrwnic. and dcpending am she mute
`cf acimiaiistriuiuza {or insmsace,
`fw’ intra-spinai er i::ir.:x-
`cirsienmi muies}. antinxiaéanis; and gmzservzatives may mt be
`zsiinweci. For :1 given drug, the rig}; 01" aeiversaz events is
`hfigher ii‘ it is adminisiered
`an irajeciicm versus 2; mn-
`parssmerai r£3uir:.Ti1e mquirexaxcnt fa): sterility demands that
`ihs :,'<a:ipienL<: be shit in withsmnsl azattzciaviaag or other
`sieriiizeaaimz garéisrc-35:363. These factors;
`iimk the chaise uf
`excipicntsa 2w;)§izai)1e so ma formula!-arse.
`Gsskiraiiy, z: E<m)wEeaige of which cxcipiente; 11:14.15: been
`damned min by the [TIA or 53:55 213 read)’ pmsem in :1 markezesci
`prm.ixee:1 g:r(wi(Ee:s incnmsaii zxssumraczrz m the farrnuia‘-.tm“ that
`these excigaierws win pmbahiy .3 safs fa): their new drug
`pmduct. Howcv:-.r, then: is: no gunmrmze. that the nsw drug
`pmduct wiii be. safe as zzxazigsissuzss are csnnhinrtci with mixer
`adsiitivcs. andfor with :1 slaw drug. creating Isnfcreessseaxx
`potentimion or synergistic toxic effects. Rs:g;u§aaior)' bmiies
`may View an excipiem previuusiy appmvmfi in em injeciabk.
`dosage form fsavorahiy, and M13 frequemiy requires less
`safciy data. A new 2:-:idi:Eve in :2 §"m'rnuEaieIi p£‘0(§!JC‘.‘. wili
`a!w:z}'s sequin: ssdciiiisaneé suzdics zzriding {C2 the cast and
`aismelizue mi’ pmdaxci <§e:w:§:)p:s1eIxt.
`cm the \'a1‘ima:".
`"111: purpezsez caf
`ihis paper is is
`excigzienis ihai hzwe been Enciuded in gin: formuiaaion cf
`injccialbie pmciucts marlxetesl in “If: USA. This infmmatieu
`is us): I‘ adiiy :.w:*.i§:1bie. A iilcraaiure Search indicates mat the
`3115: paper dcaiiiag with this \.\-‘LES puhiigsémi
`in 1988 I3).
`Pa‘-:hduc£.: approved o:si5§d~5‘. the US are new: c0*«'e3‘e<,5 in this
`
`i9§35..e’*n:c»:p1cd far publicaeinn :'\!:.y 16.. 199?.
`ivcd October 1,
`Re
`*;\uih'.':r EB who:n crsrrcspcnzjence sh-oz:-3:3 be afixircsscai: E0. BM. 5340. SE.
`Lmiifi. ML}. 63 E34
`
`re:view.A1s9.atcrE1e desage §‘(az'ms mt adminizmrred ;3aren:er-
`my,
`sur.-1:1 :25 solutiuns for inigzaziosa, czphthsslmic or mic
`drops, and csinunmzs were exciuaicd.
`
`Methudsicgy
`
`Physicians’ E335}; Reihrrmca published in 5994 & 15395 (2,
`33, and Einrldbosk on ingszctzabie. Drugs (4) were user} as she
`primary scarce sf information. Eniries an :-.1§
`in_§:‘.i:iah§e:
`xlrugs wen? stamm:-.riz.e(§ ix‘: an Excel xvnrksheet.
`3321951
`prcsduci was cirsssifiecl by Munu€;1cm{'es', Trade nama, Drug
`mamas, Route 03‘ Adminis1rsa1.icm, SVP1L\’E’, pH of Pmduzzz.
`Sohuant Uscni. SaiubiEizing,’Sus;sendi:1g Agent. Pmservzazive,
`Antitsxidzam, Cizeiator and Omar Fursxauiaiinam Additives.
`The rssealiing Excel sheet had informuiimx an more than
`700 preducis. This irsfcsritazziimx was mndenscd Emu e;1sy~3{)—
`mead tables. Each tzabie. hm: {seen categorized based on aim
`primary fun-ctitm mi‘ enmipiem in the fos'mu‘.IaIiLm. Fm‘
`ex:-.mpir:,. Ciiraies we ciassified as basfékzrs and mm as cimitw
`‘mg agents. and zzsczsrimies. am categofizcd as zzmiszxisinms,
`uiiémuggh may can serve as hu:"fes's. Thia classificafiicm sysicm
`was bzxtsed an mar expcyiencse in fmanulatirm aim-einpmcnt
`and (an we puéflishz-:L€ Em-.r:m2re. Such simpiiiiczsiiun avnirjs
`cisspiirsation (sf enirics and pmviiisas aha ‘alasiiers-':-:3 with
`ezssywtu-z1::1<J iablcs.
`Scams dupfiic-mien was uuuvoidabic. Tnbitss; VIE and ‘Jill
`s:-nntszin sums exeipients which rmy have misc been Eisttsd in
`me 5:33. six Iabics.
`‘Jsr'her:m'er
`the resébrrance 5g.1ecifica‘dy
`dcsignateti
`es specific Eur-M1011 to am Ersgrediem is was
`miistztez‘: in Tilbkii-I W5 and WEE. For -examples, ggiycine car: he
`used as :1 buffer or as a siabiiizing {prosccfing} aganfi.
`T§*.en::i'm‘(:, glycixm is listazi in Thbizs VI and Vii. Iwfieihyl
`parahen is 3 praservzsiive {Table V) hm aim has 3 spcciai
`function iEiA(§FiflIE1}‘€fEfl EDI“? f€)I'a!‘.u§:1tiox1{’l1’:b1&: V113}.
`The corzazenarminn (if axcfpienis is iisiaci
`gnmcemafics
`WcT;_.z1':i by ‘mltxssic (Wi'\I‘} cs-.“ vcxiumaz by vclumat §M'.-W). If ihrc.
`p:'~3LiL2s;I was iisimj :15 iyuphifizeti or powder. mesa percent"
`
`
`1555
`
`FDA Juumai of Pna rmaceuticafi S[‘,?en.'_‘.e .2. ’3“.~5;;g-,;3;_3g;~.;n;§,‘
`
`
`
`
`
`..................._.._.........H-—--.»—-————.r-
`
`
`
`Supplied £33! The British Library - "The wnzrriafs knowiedgef‘
`
`Astrazeneca Ex. 2088 p. 1
`Mylan Pharms. Inc. V. Astrazeneca AB IPR2016-01325
`
`

`
`
`
`TABLE I
`Sc-Ivems and <f::2~soIvenEs
`
`Frequency
`
`Rangr:
`
`
`
`'
`
`2
`3
`2
`24
`9
`A
`
`?.{‘e’_’/}; Viv
`73.6% wiv
`6% wfv
`Q.6~3U§7o
`3.5--‘}‘=)% Wa"v'
`*
`
`Drpc--Tesiosrcrun-39 €U;:__iuhn) 20% Viv
`Depo~TesI<1sieronc‘3*‘ {Upj9Im) 73,695 w.-‘v
`V12:-rxsrafi (Brit-‘A21 Myers) 5% wiv
`}I"ragr;xf’~’“> (Faun; vs.) 88% Viv
`Muizitest CMI5” icrazmamghty 70% wiv
`Ba} In 0113 {Beaten Dickinson}
`
`Sccoh:grE*:ir;x3 scdiatm (\‘I¢'_5'eihvA;,i£-mix} 50%
`G. 1 :'>:3E3%
`:1
`\"cP::siLI5' Cflriatszl Pu-fliers) 65% w!\-'
`50--55%
`'3
`Ativanfi (\‘»’y¢!h~Ayers:}
`4‘
`2
`Z)s:pG~IVfc:sin:sI9 (U3':j0Iu1) 2.95% Wfv
`(B.3~3’3E=
`ii
`E13143-migig (S;|_\f'yl:._‘,t:)
`I‘.-7?:
`‘:75
`I
`Termafiycin S-nfuaicz-is {I?.m-rig.) 'l5.2%
`{3.2—‘.'i'S.2%
`25
`Laposyn I13 (Abbcxi) 10%
`5—ma
`2
`Soiganai In;'.<“'v‘ ificherinsg.)
`‘‘
`6
`fniraiipiigi I,Cl§n.I.(‘£‘-),2U".:7o
`5»2€3% wfv
`4
`*
`2
`‘icezisj
`‘v'ir§Ien IMEn_§.® (StuFP‘1ar:na1"
`‘
`
`......mmmmm—. ?m.._.mm............
`
`Erccipicm
`
`Ecnzayl Bcnzsmr:
`Colifiiliiccd (311
`EVEN DI!"-l18Ih§,v'§a!LTt‘.X£lY‘.-‘.'§(I(:
`Eihimsfi
`Glycerin ((3I3I'L‘~t‘-Y-’JT.‘I
`?e:Im3I Oi?
`Pa‘3Iy€:!h_§'lefts giycszl
`PEG
`PEIG 30-3
`PEG =$C)€3
`PEG 3355}
`pflgfif.‘-"~VSI3€i§
`F‘rog.1yIen: Giyc-(3!
`Si£ETiOSS'€r Q5!
`Sezxsme (xi:
`Suybcan OH
`
`Vagcaahic «mi!
`° No dzsm :n'r1J:\bI-:*.
`
`Ike secfiamiitestisxn vsiumc
`ages were derived bases? 0::
`commmiy zssessi. TE): babies Eisi flat: range of cmxccntratien
`Issac}, typical! 0: mast mmrmm cancenuatiota cmyktzyed, and
`cxampies Q!" pmducig committing the axcipicni, wecificaiiy
`Ehnse: which use extrcmeiy Iow m high cunceniraiinns.
`
`Discusssions
`
`Tub-Ia: I Has! swlwanisz and co-solvents used in parenterzai
`proiiucts. Water for injaeartizm is the. mast summon solvent but
`_ma;«' he cambined GI‘ suhsiitumd wish :1 cmsrsivrant
`I-:)
`impmve tin»:
`sa1u'=33I'x£y an :~.(a1I:a'a3i1y 0:" dings. {ms Eike
`safI]m>e¢:r anti suyinazm are ussea‘ in a.ox:'aI pm-s:1::a:aI zauiriliim
`pmducis when: they serve as I3. fat source and :15; C‘£1l’!'f€.‘.1'S far
`I‘::t«s;0I:.:bIc vitamins, Ethanol and pro;-yicne gfiycoi are used,
`eitiler nllnne 5):‘ in ccxazabinaiioti with ozfixer s<)E\.':=:r:t3;, in more
`ihzaza 5{P% (sf parcnicfai ::o~seIvs2s:t systems. It is sua-paising to
`3:: pmpylessse giymi used more amen man poiycihylcne
`
`glymls {H305} in spies: of its higher my‘omxici£_sr and
`Iiesmcaiyzizsg 2-2I‘.f"e:e;:1s(5, 6). PmbaI:\Iy,1Iae gresence :3: gamma
`{ion :33’ pemxides in PECEE; is :1 :ra;ijor}is11im:i:>n.
`’£‘abIa:
`IE inciudfis :2 bread catcg<saj.- 03° excipiams wheeze:
`funcii-Dn in fm-znuiatiam couiai b::«—-—{£)‘v'isms§iy imparting gr
`suspending agems like ca:bz3>;y anctixyfi czeiiuiosc, sadium
`tarbmy mczihyl eeiluiose, so:-him}, acacia, I’z.w1'c§<)23c, I1y(i1'(I—
`I-yzzed gaimin; {2} Solasbiiizing, wetting or emulsifying
`agaaxzs Eike Cremcyphzzxtt I-EL, mziizaxn deszm‘ VCIEIJIEIIE, Pzxlyszxr»
`bask: 20 or SC), PEG 453 casmr (IE1. PEG iii.) czusmr ma, sndium
`dodeuyi sulfate,
`lecithin -er
`3/£335: ph-osphcdipidg (3)
`~ Aiumimam rnonosiersraie which is added to fixes} oi! In form
`viscous DI gei-Hike saxsprsreaiing m:‘.dE:tm. Foiysoxbaic S0 is
`me mos: ctmmmn and versatile s;(3}u§.=iII’:r.ing. wetting and
`ssmuisifying agent.
`Qniy za Iimited number cf chelafing ug;::n'Is am 3:59;} in
`pamnterztfi pz'0d=.=,cis; {'Fas§.‘.E=: HI). Téxcy serve its complex heavy
`
`TABLE {I
`3oiL.=tviIIzEng_3, Wetting, Stuesgmerading. Ernuisifying Ur Téwickeaming Agganis
`
`Excipicni
`
`Ensign
`
`Exursapie
`F1'£:£;I.ml’:I:23’
`':"a:I5r:r::uI§n Did Ttifiifl (Le-jeric} 7%
`‘Fri:
`2
`Acacia
`Sralguzwal I‘:sj."‘° {Schcringfl 2%
`2%
`E
`Aiumirum snonosicaraie
`B iciilini {\VyetI1-Aycszet) 43.55%
`I
`4%
`Curb-:3:<y zneihyi mifulosa
`Lispmn Dcpmg (TAP) i'J.75‘.7I> wiv
`i"I1.E--[}.?'S‘I{:-
`9
`Carhczxy iuetiayl cdiuiuse, sodium
`S1: m§in\.n':u =33?‘ Eszmdux) 65% wfv
`3(}—-55% W.-"v
`3
`Cmnophnra ED‘
`§"':mgE;::me‘9 (Briana? Myers“; 0.43 E93 wlv
`8.:-I£7i» wiv
`1
`Dcsoxycholaxa sodium
`inimlipiif-3’ (C§iraIer:} 5.3%
`1.2%
`3
`Egg yoik. g:Emsp':‘:o!ip§d
`€:~.n',=.1m-.3“ (kicrck) 15% wiv
`16%: wfv
`I
`Geimin, Hydmlzymi
`Dipriwzufl’ {§:'.enecn)
`w u
`Q.»’I~—I.2‘?é wiv
`7'
`Lecithin
`AquaMepE1yit3239 (Merck) T-“F2: w,-'2'
`755- wfv
`I
`Pe3y0x}'eihyla1ed fatty acid
`Cazdarfinc X E.‘.'.“-"‘. ('W},'E:'.i'I~f\j'8rS.i) 10%
`ICFDE-i2’3’:>
`3E
`E‘033'sz':ria-fie 813 ('1‘w::cn 80)
`C”aI::ije;;® (Aishou) 0.4% wlv
`£101»-€I.4‘.?v.’n.
`5
`Pviysurbate 20 (’I‘v.<~.t=:\ Z9}
`A‘-'§unismt5" (.I':zr:s5cn} 11.5% viv
`I 5.5% WW
`1
`PEG‘ 4!} caster mil”
`
`Prxrgrafi (Fujisasslzfi 213% wiv
`20% vlv
`I
`PIE} 5% C3510!’ r.1§I*’3‘*
`Bficillisfl‘ (Wyeth--Ayerst) 6.6% 's'~u’v
`0.5-0.-5% wlv
`_(s
`§'m'iLIm:e (E’oIyvin3'3 giyrmiidone)
`Prnteukinri {Cains} fI.£>.I8€7o wfv
`EM}! 8% 't.I',I'v
`I
`Sodium dmfccyi suIE':1II: {N41 Iauryfi suifaicy
`
`
`fiurbimi
`II
`‘E5-60%
`Ariatrospgnx {Fujism-:1) 58% Viv
`* Crcmophor EL: Etrxtas 35. §:rsiyc:Imx3,-lgucd mswr oi}, prJI§'9.‘{}‘eII‘iyicnc 35 casmmil.
`2 *‘ PEG 43 caster oii; po13'Ux§'l 49 task»: -xii. easier oi! FQE-40. Crodmra =38, puiynz
`-*:t§xyI::n-2; 4:) -.2-4.<'.-.wr a.>‘:I. Frcmchem CA»~I E}.
`*** PEG 6'1) J':3'1J.mg_:cz1arc:i caster nil; Crcmoph-'3: RH 61}. h§'drogen:1Ied gaszaz rsii PEEK-60. P1'o.(::r:?-.2211 CAH-6:3»
`
`.
`
`Vol. 51, No. 4 : .5u:y~Augus1 199?
`
`Supplied by The British Limary - "The worId's Imowiedge"
`
`II!II.
`I.I
`I.I
`I
`
`
`
`Astrazeneca Ex. 2088 p. 2
`
`

`
`
`
`TABLE EE3
`Gheiafing Agents
`
`
`
`----“F:;ci-gnieni "
`Cnficiurmiisosiiuzal
`EDTA3‘
`Dis-:)diL:m EB”.-"A
`
`Frmaacrzrsy
`9
`
`Rzxngss
`(}.03~—{§.i% Wydascg {Wyc.i11~
`Aycrstj (‘:23 ‘Yo wiv
`0.91-i}.§% {faicijaxw {Await}
`LI} We wiv
`F0}!-'i!Cg‘ (leiiericj
`0.2%
`E-'!agrsevi51‘° {Serf-isx}
`i‘.*.«J—§‘z?-3
`E
`1T>'i’§’A*"‘
`U,€3-1%
`"' EDTA
`iii‘:-.Eenediarrxincaerraaceiic acid,
`*9 F3TE’A == DisrihyIen::triamincp<:ntaan.xic .1cid'.}’crxiciic mini.
`
`m?~:icity (7, S). Baziyiated §';}’£§3‘(!Pé}’ aiaisuie, §su£y§at::d Emimxy
`{cinema and gmspyi gzziiatrs are primaziiy
`fin Semi/non»
`aqeemxs vehicics becrzmse of their Bow aqueous soluhiiiiy.
`Ascorbic acidisodiusn asccrbatc may same as an amiexin
`dank, buffer, and chniating agent in the .S.'.l{2'E*E formuimian.
`Benzyi aiccshoi was me mos: cummcm zmiimicruisiai
`preservzative present in parenierai 1‘c-rmnlaiitms (Tabie V).
`'I'h§s is cmasigient wiih ether suswys (9). Parabens are: the
`maxi mass mmmon pre:«:erva1iva=.:';.Thi.ri.y-rains: products»: had a
`szombinsziizm afmeahyl and pmpyi pamhens; eleven had on} 3.’
`methyi, and one haxi smiy pmpyi psraben. Thimemsai was
`suzpr§.3inggEg.' common, especinliy in vaccirtczs, Ewen Hhuugh
`some individuzais have sensitivity to mitrcurics. Chierocrcscsi
`is purported to be :1 gear} gmaservaiivr: for pzmznzerztis. but
`our survey ci-Ed mt
`find any emnxples of cemmercinl
`gmxtiascas (:cmtain§r:g chi-.aroc1'eso1.
`Table Vi lists buffers am: chfimicnls used so adjust ihc pH
`sf iormuiaiions. Phospllssie. ci:z'ate:, and acetate use the maxi
`common buffi:~.rs used in parenteral products, Mono and
`diesthanzxiarszinee are added as adjust pH and form correspond-—
`ing saiis. Hydm-gen bi'(m’fi£i:2, suifuric: amid. banzcsnc sulfmic
`aczéxi and mathanc sulfa-21$: acids are added :9 drugs whicsh
`are bmmide ificzagmiszmixue H335‘, Hycscinaa HB1", UDL),
`s:ui§'sie {NebCin, Tabramycin sulfate. Lilly),
`§3esy.L“-is
`
`Smiium EEYI‘.-"1
`
`1
`
`finZ€19‘a
`
`niemis and iixerefasu can imgxeves the: afficacy sf antioxi-
`dants or press-:=.z*v:21iveas. In our opinion, calciurr: EDTA has gm
`advanaagget «over tetrasodium 5:12‘: by not C-Driirihuiing smiium
`and not ciasiaiizwg cahzium z"mm that blend.
`Ar: axxiiuxisiarrz as a ciax;-e is defined as mass: mmpounds
`zhai can act as mducing agents or may serve as fie-3 rzuiicai
`ssczwengurs. Tabie EV summarizes Khe antioxidams. aheir
`frequency of R356, concesairsziien range and axazmgzles 5):"
`products «tonznininag témm. Suifiia. bisulfisc, and m:2€abisu}~
`fits: wnstiiui;-e the mzzjmiiy -nf antiaxidanfs used in paremcra}
`proaiucfis despite several reports of i:1compaiiE1i’!iHc.s4 and
`
`TAESLE W
`
`Anfinxiciants and Reducing Agenzs
`
`§*‘r1=-:§uem;y
`4
`7
`38
`3
`3
`2
`E
`
`Excmimt
`A-.‘cmn:: wniium bisuliiic
`A3$0r{1aifi(SudiuriIv'sJCiii)
`Bisuifite sodium
`?3\:SyIa[ed hydmxy as1isuIe(I§§-EA)
`Butylzlle-15 hydraaxy iaizaenee (EH '1')
`Cysi-2in:‘('1ysi::is:::rc HCE
`Ifmhioxxils sodiuasi (Na Elydruzulffls, Na Sui?»
`ox)-late)
`3
`Geniisic acid
`3
`fiemisic acid eihanaiamine
`2
`Cihxtamate nxtrrmsmiiiam
`9
`Formaideizycie 5l£]f()3;_3'§fi§iE! ssdium
`E
`Meiaxhisuifiec potassium
`2’,
`Meiabisulfaze soziium
`6
`Mlnnoihiagiyccml {Ihi-.3gEg.'cero!}
`2
`Pmpgii gallant
`Suifita sodium
`1'
`
`ThEn_,<_:E_vco}ate: stadium
`E
`
`Range
`G.2~»C-'.4‘fb wfv
`(3.1-4.1%‘/7: wiv
`|1=3E'.v-0.65’3E wfv
`E}.0f§f§;‘:8»»0((}3‘}.'a w.I'v
`3.00! lfi-53.63% wlv
`CID?--{3.!E}’3E,~ wh-
`G1}fl"/79
`
`€}.C}£'.% wlv
`2%
`0.1% wiv
`€1.€}’?5~(3.5% wfv
`G.§'3‘3-:':
`0.32"} $7.: wiv
`CL!-E 9?:
`0.82%
`0.05~—Lh2‘7a wfv
`{§.fi6% wiv
`
`Exazxxpie
`
`Navscainefifi {Emmi-wiruE:a'cp) €}.=§% wlv
`'s:'ibr;un)'cinfi' (fioerigk 4.3% wiv
`Amikin” flflrisml .Mym'5) 0.66% wfv
`A«.w::s:3P'°(.t‘v.:s:.1)L'=.€}3%
`Aria.-225039 (Asirsa) (3,839?
`Aczhar Gcli’? (E-1imne~Pm\!m1L‘.} §).E% win:
`Nm'r:orpho.ni' ([iuP:;<r-.1} '13. E093;
`
`Ocircoficanfl fikiaiiimficrodi)
`M.‘J.§. 127“ {Axum} 2%
`Vnrivasfi’ {Means}-:3 -I13 ‘/5 wI'v
`Tsn‘::mycin Sxsfum‘.-n Ekrmig) (15% wiv
`Vasnxyiib (Giaxrs-Wrrilcnmc) 0.10%
`faamagt-in"3‘ (DuPant} 1 E wiv
`Temsrnycin Scluiion (Rccrig) We
`Navaaag (Biaerig)
`Enionfi‘ {0E1m&da‘) (3.2% My
`S::s~F‘E1Iin::® (Forest) 0,66‘;:‘: xvlv
`
`TAR? LE V
`Antimicmbiai P.ra3sesvaiiu'es
`
`
`Rang:
`Fxcqnsency
`lixcipieni
`i).-'J2'% wiv
`E
`Benialkonium chlorida
`Ceiesione Snluxgzaafi’ fifichcriaig} 8.02% wiv
`K'3.=3"i%
`Ii
`Baxxzciiloniussa cixlorigflrz
`§}:*.z1a1dry}9 {}’qr1:r:~D;svi5] 0.01% wiv
`(},'?5—S%
`‘M
`B=:r1z_yl aim}:-01
`Dimcnhyxirinaicip {Starla} 5%
`0.25-(15%
`I7
`('.'.":lm'a7}:uKa::ui
`(iodine p‘a‘msp3r:r.i<: {wyrcsh-Ay<°.is1) 0.5%
`E}. 3-0.3%
`3
`m»-Cress!
`H13mau‘o_pe3 {I..i!!y) 6.30%
`(}.GE 950. E 59% will
`2
`Myristy! _-:;:mrunu—pic0!inimn cizioridc
`Dr:'pu~§’a‘o&'cx:1‘9 {Upjs.1hn) fh. Efs‘§3‘.7o wlv
`9.3543. 189:
`50
`Eflxrufincsa zxxcihyl
`I:=.:.a§3nm:°19 fijzmsssn) 0.!$% wfv
`€3.53--(3.3%
`-‘Efi
`Pmzben pmpyi
`Xyiocaina: v.=.-ffipitxepiwrizae (.3s;::r:1} 0. 5 ‘/5 wiv
`(3.2--GL5‘-'70
`4-S
`Péirzncyl
`l".':1ici:1‘.ar3 {Rhone Pcaulzxnc) 0.5% wiv
`€15-fl%
`3
`Z-P}s:n0.xy:*:!hanoi
`H:wr'Z,\s“' {Smislzminc §}cer!1s3m}D.5€.=*'/E; xvlv
`8.E)Gi%
`3
`Phcnyl nzercuaic nitmie
`AmivenEr3‘° :f‘eVycth-Aycrst} E309} 9?;
`
`Thimcrr32s:\J i).{)03—(3.GI ‘/2: 4%
` Aa_s_sam'39 (U;-john} 0.01%
`
`
`Efwsmpic
`
`
`
`FDA Jeurnai aé Fharmaseazeiaai Science & Te::h.rm:'agy
`
`S-uppiied by The British LEE:-rary — ‘The worfsfs kmzwiedge“
`
`
`
`
`
`Astrazeneca Ex. 2088 p. 3
`
`

`
`
`
`TABLES Vii
`
`Buiking Agents, Pmfiecianis, and Toniciiy Adjusiois
`
`Excipimi
`Aianine
`Albumin
`Aibumin humzm
`Arnim“: acids
`L-A gimme
`Aspurngina
`E.-Aspzmic acid
`Caicium. Eisluride
`CiirE:3 amid
`§3€J€i[l‘(R‘3:“:
`f§c3a:'m Eaydrc-Syzesfl
`Giucoses
`i'iiycw‘in
`f3i_'y'»:§s1e
`Hifiiiiiilfie
`
`Exnnapin
`’1'hmmE3ate EH9 (fiayeerj
`Biutiatrfi (Arm)
`Batnxfi {.!\!icrg::n}
`I-Eavz‘§:e4*(Ss31iE§1F{Iisav: Bccchmn)
`Ac1iv:ase9 (Ganemech)
`Tm:-2 BCGE {Oganon}
`Pepcidg‘ {E\*E¢2zc5:}
`Pizczucrgssn Enjcminnfl” {W’ycah~Ayers1)
`Serssorcaine-.\,{PF3“ (Astra)
`Betasemrfi (Bcflex)
`Ac::~:a:~'F9 (E{}mPe—E’:2uI:3nc Rerer)
`Ivs:r:gam'3 (Emmunu--US)
`Tics ECG3 fiflganan}
`{sigma inj¢cz§0:1‘9 (Upjohn)
`Antiisexmphilic Rctar, human
`(Am. Red Cmss)
`He!ixaic?“{Ann-315:)
`Oc1r(:aStan"5’ Emaliinckrndxj
`Caverjactfi EUpj0}m)
`Te namyciaa Snlutitrrf” (Imerig)
`‘ice ECG” iflgxxncnj
`Eisgmrfi (Merck)
`Bioclmfl {.-ikrcu)
`Ht".]ix:v.tc‘1¢ (Armour)
`V;s:ivax“” {M<3rcis'.)
`.:5.§kcran’5“ (G! axu-W:*.ilcome)
`W'E:1RZ'1-1.‘: SE33‘ {UnZ\'u:<)
`Actinimuncfi Cficnanicch}
`Dc;su~Psm's::'a'3‘ -(fipjtzhn)
`“'a;mhx‘.::~.:*.ii:-3’ (Abbott)
`Pmiastinfi (Bays;=r}
`
`§mi<.iazuk:
`Inosim!
`Lmzmse
`Msgnegium chionide
`Ma_g:,21esium suifzzic
`Man :1 ital
`Poiyeihylene giycoi 335$}
`F-siyscxbate
`Potassium: cizlorlds
`Povidnnc
`S-uiiium chfinrida
`Stadium succinme
`Sodium suifaic
`Smbitc}
`Sucmse
`
`Sgzseciai Aziciftives
`
`Thcse additives have been included in phamiaz-.1-::ut':c:3§
`forrmzlaiism m mrvs: spccific functicms {Table VH1). I.’-slow
`is a auzxznamy of tizct sgcciafi
`'e.ddiEives akmg sxriih their
`inteniied L:se--
`
`(E) Calcium giuconatc injrsction -(American Regan!) is as
`smurateci saiutiorz (bf 10% wfv; czxlcium =.i~succEmra:¢
`tets::h3‘dra1Ee 9.45% wiv is misled £0 prevezai cry:s1;1E€i—
`zaiicm during iemperamm fiuctuaaticms.
`(2) Cipm {W9 {CE;a;-aficomcira. Bayer) mntzsins lactic
`acid as in scxluhiiizsixxgg 34,2131 furlha zamibiotic.
`2:3) Prem::ri:1Injec::i .31“ (flonjazgaieai F..»;trogexss:, W_=,Iezh—
`.-5.y'er:~.§ Labs) is a 3y0p§3§§izr:d pxmilsci that contains;
`simeiixicozm in prevent Ebrmatiota of foam during
`rcccenstizuiican.
`~
`
`3311", _F<:re_s:,
`(4) Dexamaihnsozac uceéate {IZ%aEs1E:.me
`Dcczdmaz-LA, Merck, {)zsi;1imxeE1‘=PEnjess:fics:a, UAD
`Labs) and Dexamexhasane Na phosphaie (Mz.=.m;;)
`are awzqiisabiaa
`susysensitm or seamion. These (iam-
`meihascme fsznnulnrivns cemain crcaiirac er cremi
`nine
`an adriitive.
`
`(I)s)x(3:ruhi::in hydmchiorid-.2,
`EQEJEW3’
`(5) .<‘scEa‘i=.a:I:32ci:a
`Phnrmncia) conmins mcthyi paraben, 0.2 mgImL, Ea
`incmase disstalutiota (£0).
`(£3) Ergfiiratfi zzxaimic (Ergonovins anaksazrz, Liiiyj con-
`iainrs i}. 1% why} Ezaclatee 5325 ex 5-nltihiiizing agent.
`(1?) Esztrsarjurin Injection” (Pclyesmdisl phcesphate,
`W_§vv3£h—AyersE Labg)
`Nfiixcinnmide (32.5 mgfmi)
`
`TMSLE W
`Buffers anti pH Adjusiing Agents
`Excipiczii
`Kxcciaic
`Sodium
`Acetic acid
`(312932! acetic acid
`!%.mn*.<mium
`Ammonium Ezyairuxizie
`
`Exaznple
`
`Miacaicin §n_iec:ir3n@ (Szmdtr-2'.)
`Miacaicin Enjeciiaafi {Sam}-.3z_3
`fsrevitfmc I33j&»:'§io:17" iflhmecizz)
`Bumex injeaaicng‘ (Roche;
`Triosmt In}:-:::{§mf5‘ {fimiléziéiisxrz
`Bccciutan)
`Tracx-Eum injeciicz-(35 (G!axo~WcE!come}
`Valium Enjeczicn-“'9 (E-§0ch2}
`Ccfomn Enjeciirirsw gzcnemi
`Hy§mRE10~D‘~'” (Bayer)
`
`D'H‘E(.‘,—[3-orwsfl {Bayer}
`Ceredascx’ (Genzyme)
`Cerezysmzfi (f.3'enzy:a1a)-
`Ccrez)-1:15“ (ficnzymci
`Bncixins EV” (Racks)
`Qa3ini:2ir:zE°’* (Liiiyj
`Heg:—B Gum m:;§_:ees'39 (Merck)
`Ami-gar?’ ilmmlmex}
`Scopoimmnc: (UDL}
`Fentenyi mimic 8; ijropeaidoi (Astra)
`Eminaac Iaajccaion?’ {Roberts}
`Libriuan lxsjetsiondi (Rocha)
`DEE-if-5 Erxjatiictx-.5" (fiandmc)
`Term myci:1’30§:It§uri q‘_Ruar§g}
`
`Benzene suffimic acid
`E&‘.nzome Sodiuammic!
`Bicarbonate S-udismx
`5:£!TbUI}‘.lii’! Scxiinsm
`Citrate
`A»-si-;i
`Sodium
`Disodium
`Tri sodium
`Diraiinasaulaanizxr:
`G uccno dc-13:2 Eascicams
`Gfyszimz
`Ewiyxlzociaéaric acid
`Hyiirogen Esmnxida
`Lactate acici-'Ss3s.iium
`Lysine:
`Maieicr acid
`Zbieiisarscszzifezaic aa:Ea;i
`Mmxoeihanmamina
`Phosphate:
`Acid {;3§sr:§pIs<;s‘ic}
`Mcnahasic patasmxm
`Monubasic ss3dium*
`Dibusic sodium“
`Tribasic sr-fiium
`S-.3s.EEa.am hyzlr-nxiclc
`Eiulfmic acid
`Tzmraic rxcidfsnrifuxam
`’E‘r:3n:el}:.um§ne
`
`Hu:megcn’5‘ (wgamml
`'Z:\fiEnc Injcczionfi {(3¥ax0—‘p‘e'cE3::om¢}
`Pre;_:nyii° (Orgarmaa)
`F'ru!:1siin'”' (fiayex)
`S3.-:1Ehrui£i9 {Knoll}!
`Opiirayfi {MaiEinc}:rfid1}
`Nebcinfi Eijiiyji
`I»3e:sher§;Ea1e:Injc:r:rE=.2n“5“' {E‘;:‘.nd<;z)
`Q;?!ir:1}-"~‘?7t'i\.’i:x3Einc3<m<€E‘9
`* SD-flit.‘-m biphaspimic, Sodium dihydrcgen ;1I':(;.<pE1:sI¢ £31’ Nu dihydmgen
`onhophnsphmr.
`'
`** Ssxiium phosphaic. ilismiissm hydaogen phossahaic.
`
`Cfracrium Haj, sits‘.-’:curimn besyizms} or me5.'};*i;1te (Y3H~EE-Z 45
`Ixajersfaosa, D1hy:l:‘ocrgot::minc, mcsylazefi sums. (}!u::0m) deilzx
`incmnc is used to adjust ah: pH of Qaziuidine gluctairflifi
`{i'..iEiy_). Bexzzrasste buffer, 232, a conr:eenam1i:)n af 5%‘ is assazsi ‘an
`Vziliusn Enjctczizm. Cieratcs are common buffers {hat can have
`2.! dual rel as chefiaiirsg agcnis. Lysine and giycine are amino
`sci-:15 which famitfiirtm as bliffezfis am} staiaiiize preicin and
`pepzific fersmtiatiom. ‘Fhcsc atazino acids are aim used as
`iyu-asldiaives and snag gnrcvcm mic} (EtSm2.i:11‘ZzEiCx-£3. Lactate‘
`and zamratcs are caccasionaliy Usti as bui‘fer systems.
`Tame ‘HE Eirsts aciciitiwr; which are used is nmriify
`osnmiaiity, and as buiking or i;,rr..e«-L~ryr3 ps'ob':.ciivs. agents.
`Dextrose and sodium cixluridc are used is ;1dju:;i inniciiy in
`ma majority of fmnuizuions. Same aaméém acids,'giycine,
`zalzmine, hiszidinc, irtzidazeie, azginine, asparagine, aspanic
`acid, are 12345:} as buiizirsg agszms for Iyephiiizaiimx and 31133’
`serve as stabilizers for proteins or gteptizics and {ES buffers.
`Tvianusacchatides: {s5¢:xi1me, giucese, iacmse), ziiszsccharide
`(su::mse), psi}-hydric aimhuis (innsitai, marmizol, sorbitoix
`giyml {PEG 3358), P<wi<t0ns: (5;:(33}'Vinyip}'rrQ§idonc), and
`- pmieins Qaaibtamiaa,
`_s_3::ie:f.in) gm: cummtmiy used as Syn»
`additives.
`
`V:-i. 51, Ne. :3 1‘ JuE‘;~Augu:3E 199?
`
`
`W ..
`
`Astrazeneca Ex. 2088 p. 4
`
`

`
`TJEBLIE WEE
`8_:1s3ciaiAdt§i=.Zves
`
`Exaznmic
`Human Albumin {Amcrieasa Red
`Cross)
`Rccaszabinant H539 {Merck}
`Tetzzssiss Tmsziai rkaisurbcdfi
`(L£d{:s]c)
`TD /‘xdsorhezi Aduixg“
`(Ci3flflEJi.lS_h1)
`Em‘m:ase‘5’ :‘.R{:=§3e.:1s)
`Caictium Glutamate {AH1}E31'§L’£':I:":
`.
`Regcrxz)
`Human Mémmisi {Amc'ric:-.3‘: Red
`Cross)
`Diancnhydrinnte (Sieris)
`Damione D?” {Fares-)
`
`H_v<§3'ucorlcnc PE:
`(Merck)
`Cmlnay (I‘»’§.'A§3§:1cE~;rodl}
`Cnrdimer: {Sq11E'L1b}
`Engmma maicaicfi‘ {Lilly}
`Aaxuinsgsiiyllirmfi {Abhmfi
`Iinbikinascfi“ (PImrmac§a}
`Tics RSS3‘ (Ogarzrsn)
`Cipro EX”) {Bayer}
`Ealaeiexfi’ (fiieamca)
`
`Altznzinum potassium sulfatrs
`
`Ewsipiena
`
`Acct}-i irypmphzi FEZIIEE
`
`Aiuwinum h3'dr::r.1ide
`Aiuminum phosphate
`
`E-Amirmcapr-mic :3-;:i-d
`Caicium <§~sz2:char:s:¢
`
`Czxprylatc smii-.:m
`
`8—Ch1urmhe:a;3hylEine
`Crcsaasi ne
`Creari nisaa
`
`Dinzrizoic acid
`Gamma Cyciadexia-in
`Ethyl !::ci:1Ee
`Ethylenediamine
`1..-Giummate sr.::..'fium
`Irma ammcmium citrate
`La-xsic acid
`D.!_rLac:ic and Giycaiir: acid
`mpo!_5':nr:r
`Mxahosrs
`hieglumine
`Niaaarinsamide
`H’a1'ahcn :'r1r:my]
`E’:-umrnine
`
`Simcihicct-as:
`
`E*:'s';sIi:L1m szaccharin
`
`TIE-n-bI,:s.yl phosphaic
`
`
`
`‘
`
`Gamimunafi’ {K33}-ci]
`Mngnevistfi (BerIr:.=:}
`§sEr;sL§13r§n“9 {Swath-Ayersi)
`.»"uirEamyc‘m RDF1° (Pha1'rr1z1c§a) .
`Iafiuiasmrci NFH3‘ (Nova
`Norciiéici
`?r::sn:u'En Hnjcciic».-'s’3 €Wye£h-
`Ayersi)
`Cnmpszinc injeciiozlfi (Srni:§1~
`Kiim: Bnccham)
`‘\.'ezmgi:r‘csu]in'='-‘ {Apha Them-
`ptrutiw.)
`Binclasicfi‘ (Arcs)
`Lem: Ensuiinfi {Nova Nardisk)
`
`
`..~--n-..u..\~.‘....,,._
`
`TABLE Hi
`
`
`List of Excipisnt =‘rcsm 1995 FDA ‘inactive irsgmdient Guide‘
`Ammenivm suifate
`Bttnzyi chloride
`Buzyl pamben
`Crdtiiarnide smiium
`ifaltcridmi calcium
`Caste: oi]
`Cellulose imicrucrystasliinc)
`Clzoiesmoi
`E330-xye:ha’§Ec acid
`Dimrizck acid
`
`Psszsatimc (DTPA) caicium
`tiésediurrs
`§’o1c>:<:una:r E65
`PEG 4090
`PEG 2%.’!
`Fciygiacsin
`Poiyiactidr:
`Pofyaxycihicnc fatay acid
`asaera
`}’oij;c3;cymhyiene. ssrbitan
`mozmsteraze
`F‘oIy‘ox'yl 35 Czesturoii
`§’o1ysm'E>:-.39 40
`}‘-‘oIys;ur§3s.a«:=. E5
`Pr:-zaszsium Bay-riroxizias
`Fomssiasm phosphzlm, dlibasic
`Sudiuzsa bisuifzuc
`Stadium chksraie
`S-miiu m hypuchioxiaic
`Smiium iodide
`Sodium pyrnphusgxmig
`Sszdi-um £§:io:3=.xIfa:e, zmhydrous
`Soziiurn :;‘En1r:rapE2mph.'m:
`Sorbimn mtmszpasimiiaitt
`Srzmnous chionlizw.
`Stzmnmus flaaoridv:
`Smn:1m2s‘:a:1r::Ir;=
`Starch
`Sxsccisaati
`Succinic acid
`Suifmmxs acid
`Temslzis (E-i.mcyann-'Z~:m1-
`ihoxy-2.mer.h_y£~pr0p:1nic)
`copper (E) T:
`Thiazsuximic acid
`Triihizznxinxic acid
`Uscu
`Zinc acetate
`Zinc ciwiosidc
`Zinc oxide
`Zethyl he): ursrgic ::¢:i:J'
`PEG vegeiabie 0::
`
`Diuyclohexyl caritmdiimida _
`Diethyl szminc
`I3is:1;n'isE0§'E Eeciihin
`Dim}.'rir;1:3yi p?1osphafiidyԤ-
`giyceroi
`Dis0f<:nE::
`Dis-tussle sodium
`Edamine
`Exumetaziana
`Ciucepme stadium
`Gluceptaae cutcium
`GI’-.:cumn'u: acid
`Gxmrsiaiinc HG}
`Iofausmine HCE
`Lncicsbimaic acid
`Lvzciahin hfiircgenated soy
`I..iL§ufs:z'iE.=1
`Mcdmfcnirz
`Priedremata aéisodiaam
`M:.*.dr0!x§£: acid
`Meihyi hcmnic acid
`Mteiiiyl cclititrxsc
`Mmhyicnc bluc
`N~§ca:bazmuyE»-zzassshoxy poly»
`e:i1yicnc~g1_'y-mi I-’.GO0)—1,2.~
`disiearc-gyi
`N-Zuizyciroxyclhyi pipeamzinza
`N52‘ mhatne sI.=,EphonEr.'. acid
`Nioaime
`Nilric acid
`Ox}:-quinoiine
`
`as as suiubilizing zxgem. H;~;<§s3i:ra:sa§‘3 {Merck} aim
`mmains nizzcinamicic.
`
`form of aiuminum hydroxide,
`Aiuminxsm in ihae
`aiumimsm ghraspimte or aiumimzm potassium suifase
`is Lssassci as acijtevzam in various vamcim-: fnnmxiaiiians
`to cficit an incmasscssi immusislgenic response.
`EcEassicx® ((}os:ere§in zuceia
`Zcnaca} is :1dminis~
`zercd suiacuaanmusiy mirsrospheres. These spheres
`are nrizide cn1’D,E_.-=Izza:i.i: zmd giycstnlic acid copolymer.
`Lumen Depot izsjectianfli (TAP) are iym:-hilimd mi~
`crosphirres af gciatin mac! gEyc0lic~i:1c£ic acid is:
`immnlusculm‘ irajectizzn.
`Galmms. cyc.(,=eie:<srin is used as :1 stabilizer in
`Czmiimecfi at a cancemration of 50 mgfmL.
`Sodium -:::_\pr3.'l::E<.: {sadium ocwaze} has sxntifungzai
`pmpcnics, but it is 315,0 used 1:: imprawe she siaa§3iIEL;.'
`of aibumin ssiuii-on a1g::inst<:E'fes;1s
`maxi, Albumin
`satutima can En: heat g1;:.~si::uri:r:sa&i by heating :1‘-I 69°C?
`for ii} Hams:-s in Le presence «pf sodium capayiate.
`Ac-eayi E;”3'§3!.C:}’3h:1n£xE5 so-;iium is also added so aims-
`min f<3rm‘.}§:3t.i:3ns.
`Meggluminc (N«m:iEa_y1g}ucaxn§ne§ is u5;e:i as an ex-
`
`{E4}
`
`{E3}
`
`in-Sim salt. F03‘ exzzrnpiah, dia-
`cigiient mini 30 fem’:
`trimic acid, am X-my contrasi ngem, is mcarc stash}:
`when auzmiaved as megiuminc seal: than as soziium
`sait (H). Z'Vi«:gitsrnin: is aim zisidsd in M21g_:n{:vi's1°°, a
`rmgnse1icz'eson;1nce ::s3ntm.s*; zaggent, furmulaiion.
`Sumdsingiy, susfixsm saccharine is used in S£ei::1ine@
`and (fonipazinfl fornmiaticms; mar guess is than it
`serves; as a siaabiiizer and tcnEciIg.'adjas.~;1er.
`’E'riA-1':-Ezutyl phnsphsaic is present as
`cmipiesxi in
`Ezuman immune gksbuiin sniutian (‘u’camgEahuEis1®}.
`I15 exact filriiiiitiil in the fornmimimx is not lazrmwn,
`but it may serve as a scavenging agem.
`wan \“«'i'iEr:br;su1d factor is usezi so smbiiizc recombi-
`sum: zmiiixmzcphiiéa: factor {Bior;§sx1e@j1.
`Eflaliosc servaes as a: :<mE:ia.; adjuster anti s§z£biii;=.v::' in
`immune ginbulin f<ar1:1u.l£aiE0n {Gumimune N3’).
`Epsilnn amim) Capra-it acid {flaming lmmnoic acid)
`is used as a stzabiiizrsr in zmimregxizzse{E:niams::i:1§:e»;:-
`tiz)n'5*“}.
`Zinc and pm=.::misa:': 5:.-we been uddad its iazsuiin in
`f::n‘n corrmiexrczi and central aha dm-atiarm ofnciinn.
`
`
`
`PDA Jcurna! :2!‘ Pharnmceuiicai Science & Tschnoiogy
`

`
`(9‘=
`
`E2}
`
`‘WC!
`
`Supplied by The British Library ~ "The worEd‘s kno::wiedge"
`
`
`
`Astrazeneca Ex. 2088 p. 5
`
`

`
`Recently, FDA. has gsaxbiisfmi ‘lnacstive Ingmciient Guide’
`'
`'
`which H335 325 this excipiems in aiphzlbaticni arder Each
`irsggresdieni
`is foflmvszd by the route of aiimizxisitafiion (for
`csmmpis. iv, era!) mad, in £0m«:: ceases, this range afc0nccr3tr;:—
`.
`,
`_
`mm ijsggj in mg gym};-;;\,:g;§ fimg pmdgm, ¥'}Q“,'e\:g:gf’ this 555;
`goes rm: Pmwda me Emma of Cnminammi ?md“:§(3) 59759‘
`Sporzdirzg ii? each axcipient. T.-’:E3}t‘. IX E3 3.1 Sl!rEi3‘I1¢’XE’}’ Sf 23“ the
`excipients which are: incfuded in the ‘Iamcfiiw: ingrcdiani
`C 3 ob W;
`_I A
`._ Fnré
`H ‘db R
`i am 1?”
`SHE 6.,
`U;
`0flUi'Zi§.}‘.>.,£1a‘ 1:3
`.
`. .01‘
`an
`no on n_;..g,{aL...
`Drugs.
`
`-
`
`References
`
`'
`
`'
`
`‘
`
`.
`
`i. Y. J. Wang and R. R. Hfiovmi. “Pm-Iew of cxcipicnas and nH°s my
`pur(.'nEc:r:1Ipr<:duv::s used in the United S:a:e.<.“‘ J. PtIr;'n.'r-': S»;-5.
`'!'ccf:~
`imii. 34(5),/ifil {i981}.-3.
`2. E‘hysicians’D.:sk RC9:-‘1‘t.‘-ii‘-“-31‘-,5-Y‘ 43. 3994‘
`_
`3. Pixysicians‘ Des}; ReIm:rzc¢.::d.SG, £995.
`4. L. A. Trisscl, “E{az:dEmoL am Enjccrabiz‘: B31233," ed. 3, Amctiren
`Scaciety 11:" Ha:-sp:‘:aI Pinnrrnacisrs, inc, 1994.
`
`.. K.w, Reecaénéé S.Y:§!1:bxv.-s}.j,j_‘:I.‘ysi§afhumxmrr:dbh\s«,E»:¢i1sin the
`(1.35).
`5”§5°"” “r "’m“"‘3 "°5"3"""“;*“”“"' P"""'”""" ‘W’ T""1""""" 39m'm
`
`.
`‘
`‘_
`’
`.
`{U57 L
`£’5.,
`,
`1
`v
`;1;$'s\‘:.\ ;cmE:(g4;n7g2:i£;;§;§:cEab::x!y wxih maxed sslvcm .<;y,s'E-.‘.n1s‘:.
`. E. W. Muriszorn A, §¥'.:5saii1.and R. Eiiuus, "P1‘EL‘ili!i§B_-’a.'lI')‘ new Is! 11:2
`of bisuiliis in p3n:.-rrnacfculicai
`lT::hrm:I?:r{':on." J. F:':arrJ:. 5:‘.-Z, 66{i2',>.
`SW5 (»m{?J}
`.. .
`.
`.
`M _
`.
`0
`.
`.
`t
`,,
`.LC.SEhIuF.‘cr,
`isunumnsaciglsansasph...m.u:cuuca!amnxadms.
`,1 pjm,-,;;<5(,_,§{3{[3}'3gg :\;g;,[;_
`.
`I-2. Dabbah. "Th: use of'_nrcsm':x:ives in cnzxapendiai nniciesf‘ P!'1amJ(?-
`:'cvp6.’x:r' Fxsrmii. 2&4?‘ 25963 (3 996»).
`Kaufmann. E. Miiohuazetvski, 3.
`. T. 3. Ei:mm;m.':. \I. A. Smyiha.
`i’.B‘h’:'.1ii::3v'. isnd R, F. Fudggvs. “Dx'.<.s:>Iu:iu:a iimes mi‘
`::dri:srn}.‘ciza and
`nfiriszmycin EDP?’ .~‘im. .5. Ham. P.".1<1r~a=. 45, E55‘? (1938).
`‘:1 1 W.'ms_:,
`‘E’. C. Bah}, G, E), E,.~:csnm.v: Md 1), C. Morkh-smsr-,
`“flptimimsion cf amocizive v:yr;}::s amd 5:: man 01' fairmaflaiion for
`parentern! product, Pant H: Ei'fr:<:t uni‘ counter-3'-an on pH and stabiiily of
`diasrizufc acid at uulociavrz :cs;‘.pcm:ure.i.‘“.i'. Pssrwsmn
`?‘m'z:;aL.
`3E(‘3}.‘I2{i538::).
`‘!nn¢1i\'cl‘:1gr:-flicni Giiidfiv’1'}E‘.'iS§0t:0fUfE!§jEfifflrniafinza Ecsazjrtns.
`Cf}ER,.F.':n::;uja 3396.
`
`.
`
`V63. 51. Na. 4 .' Juiy-Angus! 1997
`
`Suppiied by The British Library — "The wcr|d’s knawEea:£ge“
`
`Astrazeneca Ex. 2088 p. 6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket